Stay updated with breaking news from Genomics Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering ERS Genomics Limited ('ERS'), the CRISPR licensing Company, and IRBM
CRISPR/Cas9 genome editing technology contributes to the expansion of the creation of novel disease model
/PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with the CHUM Research Centre ('(CRCHUM),'). This is a...
/PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Applied Biological Materials Inc ('abm,'). This is a...
/PRNewswire/ -- Crown Bioscience, Inc and ERS Genomics Limited ('ERS') have signed a global license agreement for access to the foundational CRISPR/Cas9 patent...